NantHealth – $107 Million Notes Offering

San Diego – January 11, 2017 – Cooley advised the initial purchasers on NantHealth’s $107 million offering of aggregate principal amount of 5.50% convertible senior notes due 2021, including a separate concurrent $10 million private placement and $7 million of option notes.

JP Morgan and Jefferies acted as joint book-running managers for the offering, Cowen and Company acted as lead manager and Canaccord Genuity acted as co-manager.

NantHealth, which trades on the NASDAQ Global Select Market under the symbol “NH,” is a next generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses.

Cooley previously advised the underwriters on NantHealth’s $97 million IPO.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Charlie Kim Partner, San Diego
David Peinsipp Partner, San Francisco
Sean Clayton Partner, San Diego
Kristin VanderPas Partner, San Francisco
Carlos Ramirez Associate, San Diego
Adrienne Directo Associate, Los Angeles
Denise Stark Paralegal Specialist, San Diego
Mischi a Marca Partner, San Francisco
Natasha Leskovsek Partner, Washington, DC
Wendy Goldstein Partner, New York
Phil Mitchell Partner, New York
Bill Christiansen Partner, Seattle
Kevin King Partner, Washington, DC
Shannon Eagan Partner, Palo Alto
Susan Cooper Philpot Partner, San Francisco
Francis Wheeler Partner, Colorado
Randy Sabett Special Counsel, Washington, DC
Jason Savich Partner, San Francisco
Katie Stork Associate, San Francisco
Karen Tsai Associate, Washington, DC
Aaron Nudelman Associate, Seattle